Simplex Trading, LLC Fsd Pharma Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$0.82 - $1.1 $302 - $405	-369 Reduced 2.36%	15,240 $13,000
Q3 2021 Oct 28, 2021	SELL	$1.45 - $1.84 $435 - $552	-300 Reduced 1.89%	15,609 $26,000
Q2 2021 Aug 12, 2021	BUY	$1.56 - $2.13 $11,506 - $15,710	7,376 Added 86.44%	15,909 $27,000
Q1 2021 Apr 26, 2021	BUY	$1.65 - $3.87 $14,079 - $33,022	8,533 New	8,533 $16,000
Q4 2020 Feb 02, 2021	SELL	$1.36 - $2.7 $2,375 - $4,716	-1,747 Closed	0 $0

Q3 2020 Oct 14, 2020	BUY	$2.55 - $4.26 $4,454 - $7,442	1,747 New	1,747 $4,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.